Almost exclusive androgenic action of dehydroepiandrosterone in the rat mammary gland

Endocrinology

Volumn 139, Issue 2, 1998, Pages 753-764

  Sourla, Antigone ^a   Martel, Céline ^a   Labrie, Claude ^a   Labrie, Fernand ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; ANTIESTROGEN; ESTRADIOL; FLUTAMIDE; MEDROXYPROGESTERONE ACETATE; MICROSPHERE; PRASTERONE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; MAMMARY GLAND; MORPHOLOGY; NONHUMAN; ORAL DRUG ADMINISTRATION; OVARIECTOMY; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031765774     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.2.5762     Document Type: Article

References (78)

1. Anderson TJ, Ferguson DJ, Raab GM 1982 Cell turnover in the "resting" human breast: influence of parity, contraceptive pill, age and laterality. Br J Cancer 46:376-382
2. Meyer JS, Connor RE 1982 Cell proliferation in fibrocystic disease and post-menopause breast ducts measured by thymidine labeling. Cancer 50:746-751
3. Longacre TA, Bartow SA 1986 A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol 10:382-393
4. Williams G, Anderson E, Howell A, Watson R, Coyne J, Roberts SA, Potten CS 1991 Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int J Cancer 48:206-210
5. Anderson TJ, Battersby S, King RJ, McPherson K, Going JJ 1989 Oral contraceptive use influences resting breast proliferation. Hum Pathol 20:1139-44
6. Pike MC, Spicer DV, Dahmoush L, Press MF 1993 Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15:17-35
7. Heuberger B, Fitzka I, Wasner G, Kratochwil K 1982 Induction of androgen receptor formation by epithelium-mesenchyme interaction in embryonic mouse mammary gland. Proc Natl Acad Sci USA 79:2957-2961
8. Kratochwil K 1977 Development and loss of androgen responsiveness in the embryonic rudiment of the mouse mammary gland. Dev Biol 61:358-365
9. Russo IH, Russo J 1986 From pathogenesis to hormone prevention of mammary carcinogenesis. Cancer Surv 5:649-670
10. Wasner G, Hennermann I, Kratochwil K 1983 Ontogeny of mesenchymal androgen receptors in the embryonic mouse mammary gland. Endocrinology 113:1771-1780
11. Hardy MH 1950 The development in vitro of the mammary gland of the mouse. J Anat 84:188-193
12. Raynaud A 1961 Morphogenesis of the mammary gland. In: Konan SK, Cowie AT (eds) Mild: the Mammary Gland and Its Secretions. Academic Press, New York, vol 1, pp 3-45
13. Raynaud A 1971 Fetal development of the mammary gland and hormonal effects on its morphogenesis. In: Falconer IR (eds) Lactation. Pennsylvania State University Press, University Park and London, pp 1-29
14. Russo J, Russo IH 1987 Biological and molecular bases of mammary carcinogenesis. Lab Invest 57:112-137
15. Russo J, Russo IH 1989 Morphology and development of the mammary gland. In: Jones TC, Morh U, Hunt R (eds) Monographs on Pathology of Laboratory Animals; Integument and Mammary Gland. Springer-Verlag, New York, pp 233-252
16. Geriani RL 1970 Fetal mammary gland differentiation in vitro in response to hormones. I. Morphological findings. Dev Biol 21:506-529
17. Cowie AT, Folley SJ 1961 The mammary gland and lactation. In: Young WC (ed) Sex and Internal Secretion. Williams and Wilkins, Baltimore, vol 1, ed. 3, pp 590-641
18. King RJB, Gordon J, Helfenstein JE 1964 The metabolism of testosterone by tissue from normal and neoplastic rat breast. J Endocrinol 29:103-110
19. King RJB, Panattoni M, Gordon J, Baker R 1965 The metabolism of steroids by tissue from normal and neoplastic rat breast. J Endocrinol 33:127-132
20. Meites J 1980 Relation of the neuroendocrine system to the development and growth of experimental mammary tumors. J Neural Transm 48:25-42
21. Forsyth IA, Jones EA 1976 Organ culture of mammary gland and placenta in the study of hormone action and placental secretion. In: Balls M, Monnickendam MA (eds) Organ culture in biomedical research. Cambridge University Press, pp 201-221
22. Lyons WR 1958 Hormonal synergism in mammary growth. Proc R Soc Biol 149:303-325
23. Dauvois S, Li S, Martel C, Labrie F 1989 Inhibitory effect of androgens on DMBA-induced mammary carcinoma in the rat. Breast Cancer Res Treat 14:299-306
24. Asselin J, Kelly PA, Caron MG, Labrie F 1977 Control of hormone receptor levels and growth of 7,12-dimethylbenz(a)anthracene-induced mammary tumors by estrogens, progesterone and prolactin. Endocrinology 101:666-671
25. Asselin J, Labrie F 1978 Effects of estradiol and prolactin on steroid receptor levels in 7,12-dimethylbenz(a)anthracene-induced mammary tumors and uterus in the rat. J Steroid Biochem 9:1079-1082
26. Kennedy BJ 1958 Fluxymesterone therapy in treatment of advanced breast cancer. New Engl J Med 259:673-675
27. Tormey DC, Lippman ME, Edwards BK, Cassidy JG 1983 Evaluation of tamoxifen doses with and without fluoxymesterone in advanced breast cancer. Ann Int Med 98:139-144
28. Gordan GS, Halden A, Horn Y, Fuery JJ, Parsons RJ, Walter RM 1973 Calusterone (7β, 17α-dimethyltestosterone) as primary and secondary therapy of advanced breast cancer. Oncology 28:138-146
29. Segaloff A 1977 The use of androgens in the treatment of neoplastic disease. Pharm Ther C2:33-37
30. Labrie F, Auclair C, Cusan L, Kelly PA, Pelletier G, Ferland L 1978 Inhibitory effects of LHRH and its agonists on testicular gonadotropin receptors and spermatogenesis in the rat. Int J Androl [Suppl] 2:303-318
31. Labrie F 1991 Intracrinology. Mol Cell Endocrinol 78:C113-C118
32. Li S, Yan X, Bélanger A, Labrie F 1993 Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(a)anthracene (DMBA) in the rat. Breast Cancer Res Treatm 29:203-217
33. Quadri SK, Kledzik GS, Meites J 1974 Counteraction by prolactin of androgen-induced inhibition of mammary tumor growth in rats. J Natl Cancer Inst 52:875-878
34. Young S, Baker RA, Helfestein JE 1965 The effects of androgens on induced mammary tumors in rats. Br J Cancer 19:155-159
35. Labrie C, Bélanger A, Labrie F 1988 Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology 123:1412-1417
36. Schwartz AG 1979 Inhibition of spontaneous breast cancer formation in female C3H (Avy/a) mice by long-term treatment with dehydroepiandrosterone. Cancer Res 39:1129-1132
37. Gauthier S, Caron B, Cloutier J, Dory YL, Favre A, Larouche D, Mailhot J, Ouellet C, Schwerdtfeger A, Leblanc G, Martel C, Simard J, Mérand Y, Bélanger A, Labrie C, Labrie F 1997 (S)-(+)-[4-[7-(2, 2-dimethyl-1-oxo-propoxy)-4-methyl-2-[4-[2-(1-piperidinyl)ethoxy]phenyl]-2H-1- benzopyran-3-yl]phenyl]-2,2-dimethylpropanoate (EM-800): a highly potent, specific and orally active nonsteroidal antiestrogen. J Med Chem 40:2117-2122
38. Simard J, Labrie C, Bélanger A, Gauthier S, Singh SM, Mérand Y, Labrie F 1997 Characterization of the effects of the novel non-steroidal antiestrogen EM-800 on basal and estrogen-induced proliferation of T-47D, ZR-75-1 and MCF-7 human breasts cancer cells in vitro. Int J Cancer 73:104-112
39. Luo S, Martel C, Sourla A, Gauthier S, Mérand Y, Bélanger A, Labrie C, Labrie F 1997 Comparative effects of 28-day treatment with the new antiestrogen EM-800 and tamoxifen on estrogen-sensitive parameters in the intact mouse, Int J Cancer 73:381-391
40. Labrie C, Flamand M, Bélanger A, Labrie F 1996 High bioavailability of DHEA administered percutaneously in the rat. J Endocrinol [Suppl] 150:S107-S118
41. Delp CR, Treves JS, Banerjee MR 1990 Neoplastic transformation and DNA damage of mouse mammary epithelial cells by N-methyl-N′-nitrosourea in organ culture. Cancer Lett 55:31-37
42. Russo IH, Medado J, Russo J 1989 Endocrine influences on the mammary gland. In: Jones TC, Morh U, Hunt R (eds) Monographs on Pathology of Laboratory Animals: Integument and Mammary Glands. Springer-Verlag, NY, pp 252-266
43. Kramer CY 1956 Extension of multiple range tests to group means with unique numbers of replications. Biometrics 12:307-310
44. Cardy RH 1991 Sexual dimorphism of the normal mammary gland. Vet Pathol 28:139-145
45. Boorman GA, Wilson JT, Van Zwieten MJ, Eustis SL 1990 Mammary gland. IV. Hyperplastic and neoplastic lesions. Pathology of the Fisher Rat. Academic Press, New York, pp 298
46. Lu KH, Hopper BR, Vargo TM, Yen SS 1979 Chronological changes in sex steroid, gonadotropin and prolactin secretions in aging female rats displaying different reproductive states. Biol Reprod 21:193-203
47. Sortino MA, Wise PM 1989 Effects of age and long term ovariectomy on prolactin secretion, as assessed by the reverse hemolytic plaque assay. Endocrinology 124:90-96
48. Attia MA, Zayed I 1989 Thirteen-weeks subcutaneous treatment with high dose of natural sex hormones in rats with special reference to their effect on the pituitary-gonadal axis. I. Oestradiol. DTW Dtsch Tierarztl Wochenschr 96:438-445
49. Nicholson RI, Gotting KE 1986 Comparative biological and antitumor effects of antiestrogens in the rat. In: Jordan VC (ed) Reviews on endocrine-related cancer. ICI Publications [Suppl 19], UK, pp 49-57
50. Delbecco R, Henahan M, Armstrong B 1982 Cell types and morphogenesis in the mammary gland. Proc Natl Acad Sci USA 79:7346-7350
51. Griffith DR, Williams R, Turner CW 1963 Effects of orally administered progesterone-like compounds on mammary gland growth in rats. Proc Soc Exp Biol Med 113:401-403
52. Kahn R, Baker BL 1964 Effect of norethynodrel alone or combined with mestranol on the mammary glands of the adult female rats. Endocrinology 75:818-821
53. Kahn R, Baker BL, Zanotti DB 1965 Factores modifying the stimulatory action of norethynodrel on the mammary gland. Endocrinology 77:162-168
54. Beck P, Malarkey WB 1976 Serum prolactin concentrations in women treated with chlormadinone acetate. Am J Obstet Gynecol 124:578-581
55. Schardein JL 1980 Studies of the components of an oral contraceptive agent in albino rats. II. Progestogenic component and comparison of effects of the components and the combined agent. J Toxicol Environ Health 6:895-906
56. Schardein JL 1980 Studies of the components of an oral contraceptive agent in albino rats. I. Estrogenic component. J Toxicol Environ Health 6:885-894
57. Li S, Lepage M, Mérand Y, Bélanger A, Labrie F 1992 Growth inhibition of 7,12-dimethylbenz(α)anthracene-induced rat mammary tumors by controlled-release lowdose medroxyprogesterone acetate. Breast Cancer Res Treatm 24:127-137
58. Revesz C, Chappel CI, Gaudry R 1960 Masculinization of female fetuses in the rat by progestational compounds. Endocrinology 66:140-144
59. Suchowsky GK, Junkmann K 1961 A study of the virilizing effect of progestins. Endocrinology 68:341-349
60. Edgren RA, Jones RC, Peterson DL 1967 A biological classification of progestational agents. Fertil Steril 18:238-256
61. Labrie C, Cusan L, Plante M, Lapointe S, Labrie F 1987 Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancer. J Steroid Biochem 28:379-384
62. Labrie C, Simard J, Zhao HF, Pelletier G, Labrie F 1990 Synthetic progestins stimulate prostatic binding protein messenger RNAs in the rat ventral prostate. Mol Cell Endocrinol 68:169-179
63. Mowszowicz I, Bieber DE, Chung KW, Bullock L, Bardin CW 1974 Synandrogenic and antiandrogenic effect of progestins: comparison with non-progestational antiandrogens. Endocrinology 95:1589-1599
64. Adams EF, Newton CJ, Tait GH, Braunsberg H, Reed MJ, James VHT 1988 Paracrine influence of human breast stromal fibroblasts on breast epithelial cells: secretion of a polypeptide which stimulates reductive 17β-estradiol dehydrogenase activity. Int J Cancer 42:119-122
65. Martel C, Rhéaume E, Takahashi M, Trudel C, Couet J, Luu-The V, Simard J, Labrie F 1992 Distribution of 17β-hydroxysteroid dehydrogenase gene expression and activity in rat and and human tissues. J Steroid Biochem Mol Biol 41:597-603
66. 4 isomerase. Endocrinology 130:553-555
67. Labrie F, Simard J, Luu-The V, Bélanger A, Pelletier G, Morel Y, Mebarki F, Sanchez R, Durocher F, Turgeon C, Labrie Y, Rhéaume E, Labrie C, Lachance Y 1996 The 3β-hydroxysteroid dehydrogenase/isomerase gene family: lessons from type II 3β-HSD congenital deficiency. In: Hansson V, Levy FO, Taskén K (eds) Signal Transduction in Testicular Cells. Ernst Schering Research Foundation Workshop. Springer-Verlag, New York, vol suppl 2, pp 185-218
68. Labrie F, Luu-The V, Lin SX, Labrie C, Simard J, Breton R, Bélanger A 1997 The key role of 17β-HSDs in sex steroid biology. Steroids 62:148-158
69. Labrie F, Bélanger A, Simard J, Luu-The V, Labrie C 1995 DHEA and peripheral androgen and estrogen formation: intracrinology. Ann NY Acad Sci 774:16-28
70. Kelly PA, Tsushima T, Shiu RP, Friesen HG 1976 Lactogenic and growth hormone-like activities in pregnancy determined by radioreceptor assays. Endocrinology 99:765-774
71. Van Wanegen G, Folley SJ 1939 The effect of androgens on the mammary gland of the female rhesus monkey. J Endocrinol 1:367
72. Selye H, McEuen Cs, Collip JB 1936 Effect of testosterone on the mammary gland. Proc Soc Exp Biol 34:201
73. Luo S, Sourla A, Labrie C, Bélanger A, Labrie F 1997 Combined effects of dehydroepiandrosterone and EM-800 on bone mass, serum lipids, and the development of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat. Endocrinology 138:4435-4444
74. Russo J, Saby J, William MI, Russo IH 1977 Pathogenesis of mammary carcinomas induced in rats by 7,12-dimethylbenz(a)anthracene. J Natl Cancer Inst 59:435-445
75. Dao TL, Chistakos SS, Varela R 1975 Biochemical characterization of carcinogen-induced mammary hyperplastic aveolar nodule and tumor in the rat. Cancer Res 35:1128-1134
76. Nagasawa H, Welch CW 1989 Prolactin and lesions in breast, uterus and prostate. In: Nagasawa H (ed) CRC Press, Boca Raton, pp 39-50
77. Ip MM, Milholland RJ, Kim U, Rosen F 1982 Androgen control of cytosol progesterone receptor levels in the MT-W9B transplantable mammary tumor in the rat. J Natl Cancer Inst 69:673-681
78. Couture P, Thériault C, Simard J, Labrie F 1993 Androgen receptor-mediated stimulation of 17β-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. Endocrinology 132:179-185